Wego Blood Purification (603014.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 864 million yuan, a year-on-year increase of 4.50%.

Zhitong Finance APP News, WEGO Blood Purification (603014.SH) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 4.368 billion yuan, a year-on-year increase of 5.33%. Net profit attributable to shareholders of the listed company was 864 million yuan, a year-on-year increase of 4.50%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 320 million yuan, a year-on-year decrease of 3.90%.